Les Achards, France

Estelle Grasset

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Biogaia Ab. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Estelle Grasset. Retrieved from https://idiyas.com/inventor/estelle-grasset-rui0wh26

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Estelle Grasset: Innovator in Serotonin Production

Introduction

Estelle Grasset is a notable inventor based in Les Achards, France. She has made significant contributions to the field of biotechnology, particularly in the area of serotonin production. Her innovative work focuses on addressing serotonin deficiency, which is linked to various health issues.

Latest Patents

Estelle Grasset holds a patent for her invention titled "Serotonin producing bacteria." This invention relates to the selection of a bacterial strain for use in treating serotonin deficiency and related diseases. The process involves culturing a lactic acid-producing bacterial strain under aerobic conditions in a medium containing tryptophan. The effectiveness of the strain is determined by detecting serotonin produced in the culture medium.

Career Highlights

Estelle is currently associated with BioGaia AB, a company known for its advancements in probiotic research and development. Her work at BioGaia AB has allowed her to explore innovative solutions for health-related challenges, particularly those associated with serotonin levels.

Collaborations

Estelle collaborates with talented individuals in her field, including Muhammed Khan and Bo Möllstam. These partnerships enhance her research and contribute to the development of effective treatments for serotonin deficiency.

Conclusion

Estelle Grasset's contributions to the field of biotechnology, particularly through her patent on serotonin-producing bacteria, highlight her role as an innovator. Her work has the potential to impact the treatment of serotonin deficiency and improve health outcomes for many individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…